Fraud Claims Against Lilly Tossed In Cymbalta Labeling Row
A Virginia federal judge on Friday found that two women suing Eli Lilly and Co. for allegedly misrepresenting the withdrawal risks of its antidepressant drug Cymbalta had failed to present enough...To view the full article, register now.
Already a subscriber? Click here to view full article